<- Go Home
Laboratorio Chile S.A.
Laboratorio Chile S.A. develops, manufactures, and sells pharmaceutical products. The company offers bioequivalent and generic products. It serves hospitals, clinics, and municipalities, as well as private pharmacies and distributors. The company was founded in 1896 and is based in Santiago, Chile. As of July 25, 2005, Laboratorio Chile S.A. operates as a subsidiary of Teva Pharmaceutical Industries Limited.
Market Cap
$4.7T
Volume
20.2K
Cash and Equivalents
$4.1B
EBITDA
$26.4B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$72.8B
Profit Margin
71.29%
52 Week High
$16.4K
52 Week Low
$9.6K
Dividend
N/A
Price / Book Value
77.00
Price / Earnings
344.80
Price / Tangible Book Value
315.85
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
$23.3B
Return on Equity
23.79%
Return on Assets
12.33
Cash and Short Term Investments
$9.5B
Debt
$47.3B
Equity
$64.2B
Revenue
$102.1B
Unlevered FCF
N/A
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium